TDOC Teladoc Health Inc

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES                                                                                   
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940                       

1. Name and Address of Reporting Person * Fenwick Sandra L	2. Issuer Name and Ticker or Trading Symbol Teladoc Health, Inc. [ TDOC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner _____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle) C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203	3. Date of Earliest Transaction (MM/DD/YYYY) 2/25/2021
(Street) PURCHASE, NY 10577 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	2/25/2021		M		7173	A	(1)	14346	D
Common Stock								28362	I	By Geoffrey L. Fenwick Family Irrevocable Trust dated 12/17/2020 (4)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(2)	2/25/2021		M			6460	(3)	(3)	Common Stock	6460	$0	6461	D
Restricted Stock Units	(2)	2/25/2021		M			713	(3)	(3)	Common Stock	713	$0	715	D

Explanation of Responses:
(1)	Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
(2)	Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
(3)	The restricted stock units vest in three substantially equal installments each quarter beginning November 25, 2020.
(4)	The shares are held of record by the Geoffrey L. Fenwick Family Irrevocable Trust for the benefit of the reporting person's children and for which the reporting person and her spouse serve as co-trustees.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Fenwick Sandra L C/O TELADOC HEALTH, INC. 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE, NY 10577	X

Signatures
/s/ Adam C. Vandervoort, attorney-in-fact		2/26/2021
**Signature of Reporting Person		Date